Helicobacter pylori Infection in Cats and Ferrets: Gastric Ulcer Pathogenesis, Diagnosis, and Treatment

Introduction

Gastric colonization by Helicobacter species is a well recognized phenomenon in domestic cats and ferrets, with implications for both animal health and zoonotic transmission [1, 2]. While Helicobacter pylori is the prototypical human gastric pathogen, cats and ferrets harbor a diverse array of gastric helicobacters including H. pylori, H. heilmannii sensu stricto, H. felis, H. bizzozeronii, H. salomonis, H. ailurogastricus, and H. mustelae [3, 4, 5]. In ferrets, H. mustelae is the dominant species and is strongly associated with chronic gastritis, hypergastrinemia, and gastric adenocarcinoma [6, 7]. In cats, mixed infections are common, and the clinical significance of these organisms ranges from asymptomatic carriage to severe lymphoplasmacytic gastritis and peptic ulceration [8, 9]. This article provides an exhaustive review of the pathogenesis, diagnostic modalities, and therapeutic strategies for Helicobacter associated gastric disease in cats and ferrets, with emphasis on molecular mechanisms and evidence based clinical management.

Pathogenesis of Gastric Ulceration

Bacterial Virulence Factors and Host Interactions

Helicobacter species employ a suite of virulence determinants that facilitate colonization, immune evasion, and tissue damage. Urease activity is a universal feature; the enzyme hydrolyzes urea to ammonia, neutralizing gastric acid and enabling survival in the acidic lumen [10, 11]. Flagellar motility, conferred by two flagellin subunits (FlaA and FlaB), is essential for penetration of the mucus layer [12, 13]. In H. mustelae, a major ring forming surface protein (Hsr) mediates adherence to gastric epithelium [14]. Cholesterol alpha-glucosyltransferase, an enzyme that modifies host cholesterol to suppress innate immune responses, has been detected in H. suis and related species and is likely conserved among gastric helicobacters [15].

The vacuolating cytotoxin (VacA) and the cytotoxin associated gene pathogenicity island (cagPAI) are well characterized in H. pylori but are variably present in animal derived strains [16, 17]. H. heilmannii sensu stricto lacks a functional cagPAI yet induces pronounced lymphocytic infiltration and lymphoid follicle formation in both cats and humans [18, 19]. Comparative genomics has revealed interspecies admixture and horizontal gene transfer among gastric helicobacters, contributing to host range expansion and virulence heterogeneity [20].

Gastric Mucosal Injury and Ulcerogenesis

Chronic Helicobacter infection disrupts the gastric epithelial barrier through multiple mechanisms. Bacterial urease generated ammonia directly damages epithelial cells and alters the mucus gel structure [21]. In cats, infection with H. heilmannii is associated with upregulation of ezrin, a membrane cytoskeleton crosslinker, and epidermal growth factor receptor 2 (HER2), suggesting activation of proliferative signaling pathways that may predispose to neoplastic transformation [22, 23]. Parietal cell loss, observed in H. felis and H. bizzozeronii infected Mongolian gerbils, leads to hypochlorhydria and compensatory hypergastrinemia, a condition also documented in H. mustelae infected ferrets [24, 25]. Hypergastrinemia stimulates enterochromaffin like cell hyperplasia and may promote gastric adenocarcinoma development in ferrets [26, 27].

Gastric ulceration in cats and ferrets is multifactorial. Direct bacterial cytotoxicity, host inflammatory responses (neutrophil infiltration, oxidative burst, cytokine release), and disruption of the gastric mucosal barrier all contribute [28, 29]. In ferrets, H. mustelae infection combined with chemical carcinogens (e.g., MNNG) accelerates gastric carcinoma formation, underscoring the cocarcinogenic potential of chronic helicobacteriosis [30]. Spontaneous linear gastric tears have been reported in cats with concurrent Helicobacter infection, although a direct causal link remains unproven [31].

Extragastric Manifestations

Helicobacter species have been detected beyond the stomach. In cats, H. pylori and non H. pylori helicobacters have been identified in the oral cavity, bile, pancreas, and hepatobiliary system [32, 33, 34]. Fecal carriage of Helicobacter spp. is common in cats with gastroenteritis, raising concerns about environmental contamination and zoonotic transmission [35]. Cholangiohepatitis in cats has been associated with hepatic Helicobacter colonization, though the pathogenic significance is debated [36].

Diagnosis

Clinical Presentation

Infected cats and ferrets may present with chronic vomiting, anorexia, weight loss, ptyalism, and melena, but many remain asymptomatic [37, 38]. Physical examination findings are often nonspecific. In ferrets, chronic H. mustelae infection can lead to gastric adenocarcinoma, which may present as a palpable abdominal mass, anemia, or signs of gastric outflow obstruction [39].

Noninvasive Diagnostic Tests

Serology: Enzyme linked immunosorbent assays (ELISAs) detecting antibodies against H. felis or H. pylori have been developed for cats, but sensitivity and specificity are limited due to cross reactivity among Helicobacter species and the high prevalence of asymptomatic infection [40, 41].

Urea Breath Test: The 13C urea breath test detects active urease activity in the stomach. It is noninvasive and can be used for monitoring treatment response, but it does not differentiate between Helicobacter species [42].

Fecal Antigen Tests: Commercial fecal antigen tests designed for human H. pylori have been applied to cats and ferrets with variable accuracy. Cross reactivity with enteric helicobacters may produce false positives [43].

Invasive Diagnostic Methods

Endoscopy and Biopsy: Gastroduodenoscopy allows direct visualization of the mucosa and collection of biopsy samples for histopathology, culture, and molecular testing. Typical endoscopic findings include diffuse erythema, erosions, ulcerations, and a nodular appearance of the gastric mucosa [44, 45].

Histopathology: Gastric biopsies stained with hematoxylin and eosin (H&E) reveal lymphoplasmacytic gastritis, lymphoid follicle formation, and variable neutrophilic infiltration. Warthin Starry silver stain or modified Giemsa stain highlights spiral shaped organisms within the mucus layer and gastric pits [46, 47]. Immunohistochemistry using species specific antibodies (e.g., against H. heilmannii or H. mustelae) improves specificity [48].

Culture: Microaerophilic culture on selective media (e.g., Skirrow’s agar) is the gold standard for species identification but is technically demanding and time consuming. H. mustelae grows more readily than feline derived helicobacters [49].

Molecular Diagnostics: Polymerase chain reaction (PCR) targeting the 16S rRNA gene, urease genes (ureA, ureB), or species specific loci (e.g., hsp60, flaB) enables sensitive detection and speciation [50, 51]. Quantitative PCR (qPCR) can assess bacterial load. Fluorescent in situ hybridization (FISH) allows visualization of Helicobacter species in tissue sections [52]. Next generation sequencing of amplicons or whole genomes provides high resolution taxonomic and functional information [53].

Rapid Urease Test: A biopsy specimen placed in urea broth turns pink within minutes to hours if urease producing Helicobacter are present. This test is inexpensive and provides rapid results but does not identify the species [54].

Diagnostic Algorithm

The following Mermaid diagram outlines a recommended diagnostic workflow for cats and ferrets with suspected Helicobacter associated gastric disease.

flowchart TD
    A["Clinical suspicion: chronic vomiting, weight loss, melena"] --> B{Noninvasive testing}
    B --> C[Urea breath test or fecal antigen test]
    C --> D[Positive result]
    D --> E[Endoscopy with biopsy]
    E --> F[Histopathology + rapid urease test]
    F --> G[Positive histology or urease]
    G --> H[PCR/species identification]
    H --> I[Treatment decision]
    C --> J[Negative result but high suspicion]
    J --> E
    B --> K["Serology (limited utility")]
    K --> L[Consider endoscopy if seropositive]
    L --> E

Table 1 summarizes the diagnostic methods, their advantages, and limitations.

Treatment

Antimicrobial Regimens

Eradication of gastric Helicobacter in cats and ferrets is challenging due to biofilm formation, intracellular survival, and antimicrobial resistance [55]. Triple therapy (amoxicillin, metronidazole, and a proton pump inhibitor) has been used but yields variable success rates [56]. Quadruple therapy combining a bismuth compound (e.g., ranitidine bismuth citrate), metronidazole, amoxicillin, and omeprazole has shown superior efficacy in cats with naturally acquired infection [57]. In ferrets, a regimen of ranitidine bismuth citrate and clarithromycin achieved eradication of H. mustelae in experimental studies [58].

The recommended treatment protocol for cats is as follows:

• Omeprazole: 0.7-1.0 mg/kg PO q12h for 14 days.
• Amoxicillin: 20 mg/kg PO q12h for 14 days.
• Metronidazole: 10-15 mg/kg PO q12h for 14 days.
• Bismuth subsalicylate: 1-2 mL/kg PO q8-12h for 14 days (or ranitidine bismuth citrate if available).

For ferrets, a similar regimen adjusted for body weight (omeprazole 0.7 mg/kg, amoxicillin 20 mg/kg, metronidazole 20 mg/kg, bismuth subsalicylate 1 mL/kg) is recommended [59].

Monitoring and Retreatment

Eradication should be confirmed by urea breath test or PCR on gastric biopsies 4-6 weeks after completing therapy. If infection persists, a second line regimen using different antimicrobials (e.g., tetracycline or levofloxacin) may be considered, though resistance data in veterinary isolates are limited [60].

Supportive Care

Gastric protectants (sucralfate) and antiemetics (maropitant) are indicated for symptomatic animals. Dietary modification to a highly digestible, low fat diet may reduce gastric irritation [61].

Prognosis

With successful eradication, clinical signs typically resolve within 2-4 weeks. However, reinfection is possible, especially in multi cat households or environments with fecal oral transmission [62]. Chronic H. mustelae infection in ferrets carries a risk of malignant transformation, necessitating long term surveillance [63].

Zoonotic Considerations

Several gastric Helicobacter species of cats and ferrets have zoonotic potential. H. heilmannii sensu stricto, H. felis, H. bizzozeronii, and H. ailurogastricus have been identified in human patients with gastritis, peptic ulcers, and mucosa associated lymphoid tissue (MALT) lymphoma [64, 65, 66]. Direct transmission from pets to humans is supported by case reports and phylogenetic analyses [67, 68]. Veterinary professionals and immunocompromised individuals should observe strict hygiene when handling gastric specimens or treating infected animals [69].

Conclusion

Helicobacter infection in cats and ferrets is a complex, multispecies disease with significant implications for gastric health. Pathogenesis involves urease mediated acid neutralization, flagellar motility, adherence factors, and host inflammatory responses that can progress to ulceration and neoplasia. Diagnosis relies on a combination of noninvasive screening tests and invasive sampling with histopathology, culture, and molecular methods. Treatment with quadruple therapy is effective but requires confirmation of eradication. The zoonotic potential of animal derived helicobacters underscores the importance of a One Health approach to surveillance and management.

References

[1] Jamshidi S, Mozafari M, Machiani MK et al. Comparative molecular detection of Helicobacter spp. and Wolinella in the oral cavity of cats and dogs with periodontal disease and healthy individuals. Iran J Microbiol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41234637/

[2] Nurgaliev FM, Pozdeev OK, Gilmanov KK et al. Indication and identification of Helicobacter spp. in the cat stomach. Open Vet J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41200338/

[3] Fujihara D, Kurimoto M, Sekai I et al. Mucosa-associated Lymphoid Tissue Lymphoma of the Stomach Associated with a Helicobacter heilmannii sensu stricto Infection One Year after the Successful Eradication of Helicobacter pylori. Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41033996/

[4] Al-Ghafar AAA, Marouf SA, Abdel-Moein KA et al. The Fecal Carriage of Helicobacter Species Among Pet Animals Suffering from Gastroenteritis: A Potential Public Health Concern. Vector Borne Zoonotic Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40469006/

[5] Sugimoto M, Rimbara E, Murata M et al. Roles of Gastric Non-Helicobacter pylori Helicobacter Species in Gastric Disease Development: A Review. Helicobacter. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40462295/

[6] Tokunaga K, Rimbara E, Tsukadaira T et al. Prospective Multicenter Surveillance of Non-H. pylori Helicobacter Infections during Medical Checkups, Japan. Emerg Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40439414/

[7] Ahmadi R, Arfaee F, Jamshidi S et al. Prevalence and diversity of enteric Helicobacter spp. in healthy and diarrheic cats. Iran J Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39267933/

[8] Wang D, Wang D, Liao K et al. Optical detection using CRISPR-Cas12a of Helicobacter pylori for veterinary applications. Mikrochim Acta. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37910191/

[9] Taillieu E, De Bruyckere S, Van Steenkiste C et al. Presence of potentially novel Helicobacter pylori-like organisms in gastric samples from cats and dogs. Vet Res. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/37849010/

[10] Sano M, Rimbara E, Suzuki M et al. Helicobacter ailurogastricus in Patient with Multiple Refractory Gastric Ulcers, Japan. Emerg Infect Dis. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36958030/

[11] Sousa DA, Silva KVGC, Paranhos JES et al. Ezrin immunoexpression in gastric cells of domestic cats infected with Helicobacter spp. Res Vet Sci. 2023. URL: https://pubmed.ncbi.nlm.nih.gov/36512978/

[12] Taillieu E, Chiers K, Amorim I et al. Gastric Helicobacter species associated with dogs, cats and pigs: significance for public and animal health. Vet Res. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35692057/

[13] Matos R, Taillieu E, De Bruyckere S et al. Presence of Helicobacter Species in Gastric Mucosa of Human Patients and Outcome of Helicobacter Eradication Treatment. J Pers Med. 2022. URL: https://pubmed.ncbi.nlm.nih.gov/35207669/

[14] Youssef AI, Afifi A, Abbadi S et al. PCR-based detection of Helicobacter pylori and non-Helicobacter pylori species among humans and animals with potential for zoonotic infections. Pol J Vet Sci. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/34730306/

[15] Kubota-Aizawa S, Matsubara Y, Kanemoto H et al. Transmission of Helicobacter pylori between a human and two dogs: A case report. Helicobacter. 2021. URL: https://pubmed.ncbi.nlm.nih.gov/33818862/

[16] Elyasi B, Rezaie A, Moori Bakhtiari N et al. Helicobacter genus in the intestine and liver of stray cats: the molecular, histopathological, and immunohistochemical study. Braz J Microbiol. 2020. URL: https://pubmed.ncbi.nlm.nih.gov/32875544/

[17] Sousa DA, Silva KVGCD, Cascon CM et al. Epidermal growth factor receptor 2 immunoexpression in gastric cells of domestic cats with H. heilmannii infection. Acta Histochem. 2019. URL: https://pubmed.ncbi.nlm.nih.gov/30890258/

[18] Smet A, Yahara K, Rossi M et al. Macroevolution of gastric Helicobacter species unveils interspecies admixture and time of divergence. ISME J. 2018. URL: https://pubmed.ncbi.nlm.nih.gov/29942073/

[19] Kawakubo M, Horiuchi K, Komura H et al. Cloning of Helicobacter suis cholesterol alpha-glucosyltransferase and production of an antibody capable of detecting it in formalin-fixed, paraffin-embedded gastric tissue sections. Histochem Cell Biol. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28534071/

[20] Kubota-Aizawa S, Ohno K, Kanemoto H et al. Epidemiological study on feline gastric Helicobacter spp. in Japan. J Vet Med Sci. 2017. URL: https://pubmed.ncbi.nlm.nih.gov/28367842/

[21] Shojaee Tabrizi A, Derakhshandeh A, Esfandiari A et al. Identification of Helicobacter spp. in gastrointestinal tract, pancreas and hepatobiliary system of stray cats. Iran J Vet Res. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/27175206/

[22] Joosten M, Lindén S, Rossi M et al. Divergence between the Highly Virulent Zoonotic Pathogen Helicobacter heilmannii and Its Closest Relative, the Low-Virulence "Helicobacter ailurogastricus" sp. nov. Infect Immun. 2016. URL: https://pubmed.ncbi.nlm.nih.gov/26527212/

[23] Pozdeev OK, Pozdeeva AO, Pozdnyak AO et al. [Role of animal gastric Helicobacter species in human gastric pathology]. Ter Arkh. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/26155631/

[24] Gualtieri M, Olivero D, Costa Devoti C. Spontaneaous linear gastric tears in a cat. J Small Anim Pract. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/25703995/

[25] Sasani F, Javanbakht J, Kabir FR et al. Evaluation of Gastric Lesions Based on Helicobacter pylori and Helicobacter-Like Organisms (HLOs) in Cats; A Histopathological and Bacteriological Study. Jundishapur J Microbiol. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/25371810/

[26] Canejo-Teixeira R, Oliveira M, Pissarra H et al. A mixed population of Helicobacter pylori, Helicobacter bizzozeronii and "Helicobacter heilmannii" in the gastric mucosa of a domestic cat. Ir Vet J. 2014. URL: https://pubmed.ncbi.nlm.nih.gov/25905013/

[27] Tegtmeyer N, Rivas Traverso F, Rohde M et al. Electron microscopic, genetic and protein expression analyses of Helicobacter acinonychis strains from a Bengal tiger. PLoS One. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23940723/

[28] Joosten M, Blaecher C, Flahou B et al. Diversity in bacterium-host interactions within the species Helicobacter heilmannii sensu stricto. Vet Res. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23895283/

[29] Zhang S, Moss SF. Rodent models of Helicobacter infection, inflammation, and disease. Methods Mol Biol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/23015495/

[30] Iwanczak B, Biernat M, Iwanczak F et al. The clinical aspects of Helicobacter heilmannii infection in children with dyspeptic symptoms. J Physiol Pharmacol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22653899/

[31] Yakoob J, Abbas Z, Khan R et al. Prevalence of non Helicobacter pylori species in patients presenting with dyspepsia. BMC Gastroenterol. 2012. URL: https://pubmed.ncbi.nlm.nih.gov/22226326/

[32] Smet A, Flahou B, Mukhopadhya I et al. The other Helicobacters. Helicobacter. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21896089/

[33] Arnold IC, Zigova Z, Holden M et al. Comparative whole genome sequence analysis of the carcinogenic bacterial model pathogen Helicobacter felis. Genome Biol Evol. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21402865/

[34] Khoshnegah J, Jamshidi S, Mohammadi M et al. The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection. J Feline Med Surg. 2011. URL: https://pubmed.ncbi.nlm.nih.gov/21144784/

[35] Goldman CG, Mitchell HM. Helicobacter spp. other than Helicobacter pylori. Helicobacter. 2010. URL: https://pubmed.ncbi.nlm.nih.gov/21054656/

[36] Shojaee Tabrizi A, Jamshidi Sh, Oghalaei A et al. Identification of Helicobacter spp. in oral secretions vs. gastric mucosa of stray cats. Vet Microbiol. 2010. URL: https://pubmed.ncbi.nlm.nih.gov/19726141/

[37] Haesebrouck F, Pasmans F, Flahou B et al. Gastric helicobacters in domestic animals and nonhuman primates and their significance for human health. Clin Microbiol Rev. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19366912/

[38] Ghil HM, Yoo JH, Jung WS et al. Survey of Helicobacter infection in domestic and feral cats in Korea. J Vet Sci. 2009. URL: https://pubmed.ncbi.nlm.nih.gov/19255526/

[39] Harbour S, Sutton P. Immunogenicity and pathogenicity of Helicobacter infections of veterinary animals. Vet Immunol Immunopathol. 2008. URL: https://pubmed.ncbi.nlm.nih.gov/18243338/

[40] Greiter-Wilke A, Scanziani E, Soldati S et al. Association of Helicobacter with cholangiohepatitis in cats. J Vet Intern Med. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16955803/

[41] Solnick JV, Franceschi F, Roccarina D et al. Extragastric manifestations of Helicobacter pylori infection-other Helicobacter species. Helicobacter. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16925612/

[42] Starzyñska T, Malfertheiner P. Helicobacter and digestive malignancies. Helicobacter. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16925609/

[43] Eppinger M, Baar C, Linz B et al. Who ate whom? Adaptive Helicobacter genomic changes that accompanied a host jump from early humans to large felines. PLoS Genet. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16789826/

[44] De Bock M, Decostere A, Hellemans A et al. Helicobacter felis and Helicobacter bizzozeronii induce gastric parietal cell loss in Mongolian gerbils. Microbes Infect. 2006. URL: https://pubmed.ncbi.nlm.nih.gov/16311055/

[45] Singhal AV, Sepulveda AR. Helicobacter heilmannii gastritis: a case study with review of literature. Am J Surg Pathol. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/16224223/

[46] De Groote D, Van Doorn LJ, Van den Bulck K et al. Detection of non-pylori Helicobacter species in "Helicobacter heilmannii"-infected humans. Helicobacter. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/16181350/

[47] Van den Bulck K, Decostere A, Baele M et al. Identification of non-Helicobacter pylori spiral organisms in gastric samples from humans, dogs, and cats. J Clin Microbiol. 2005. URL: https://pubmed.ncbi.nlm.nih.gov/15872252/

[48] Kato S, Ozawa K, Sekine H et al.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.